You are here

Pfizer

China's Aim to Remove Cancer Drug Taxes May Boost Pfizer, Glaxo

Bloomberg

Tue, 03/20/18 - 09:59 am

Viagra Lowers Colorectal Cancer Risk in Mice – Could the Same Be True for Humans?

Xtalks

Tue, 03/20/18 - 09:42 am

colorectal cancer

erectile dysfunction

Is Pfizer's CEO Ian Read Really Worth 61% More?

Motley Fool

Tue, 03/20/18 - 09:37 am

Drug companies are beginning to wake up to this new risk factor

Marketwatch

Mon, 03/19/18 - 12:05 pm

pharma industry

Pfizer Lifts CEO's Pay 61% to $27.9 Million With Retention Bonus

Bloomberg

Fri, 03/16/18 - 09:24 am

With U.S. brand sales deflating, Pfizer gears up for over-the-counter Viagra in U.K.

Fierce Pharma

Thu, 03/15/18 - 09:37 pm

erectile dysfunction

How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment

Motley Fool

Thu, 03/15/18 - 09:55 am

prostate cancer

Merkel cell carcinoma

metastatic non-small cell lung cancer

metastatic breast cancer

Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale

Endpoints

Mon, 03/12/18 - 09:38 am

clinical trials

Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

Yahoo/Reuters

Sun, 03/11/18 - 11:59 am

Reckitt Benckiser

consumer health

Pfizer Gets FDA Panel Backing for New Indication for Xeljanz

Yahoo/Zacks.com

Fri, 03/9/18 - 10:50 am

advisory panels

ulcerative colitis

Pfizer calls it quits on CytomX deal as research comes to naught

Fierce Biotech

Thu, 03/8/18 - 11:49 pm

Senator questions big pharma buyback strategy

Biopharma Dive

Tue, 03/6/18 - 09:30 am

share repurchase

Top 5 viewed boards for week ending March 3, 2018

CP Wire

Sun, 03/4/18 - 01:50 pm

Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma

Fierce Pharma

Sat, 03/3/18 - 10:42 am

Merkel cell carcinoma

Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance

RAPS.org

Tue, 02/27/18 - 10:40 pm

drug development

This could be the next $1 billion drug, if patients get on board

Yahoo/Marketwatch

Tue, 02/27/18 - 09:55 am

sickle cell disease

clinical trials

What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two

Fierce Pharma

Mon, 02/26/18 - 11:30 am

Gilead Sciences

Bristol losing its I/O talent to the likes of Pfizer, report finds

Biopharma Dive

Sat, 02/24/18 - 10:39 pm

Bristol-Myers Squibb

immuno-oncology

If Pfizer is itching to make a major deal, Bristol-Myers Squibb is probably on its radar screen

Motley Fool

Thu, 02/22/18 - 11:14 am

Bristol-Myers Squibb

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

Endpoints

Sat, 02/17/18 - 10:44 am

Pages